A Malarstig

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction
    Anders Malarstig
    Atherosclerosis Research Unit, Karolinska Institute, Stockholm, Sweden
    Arterioscler Thromb Vasc Biol 28:975-82. 2008
  2. ncbi Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    Blood 114:1417-22. 2009
  3. ncbi Genetics of atherothrombosis and thrombophilia
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine, Solna, Sweden
    Curr Atheroscler Rep 12:159-66. 2010
  4. ncbi Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
    A Malarstig
    Atherosclerosis Research Unit, Karolinska University Hospital, Stockholm, Sweden
    J Intern Med 270:229-36. 2011

Detail Information

Publications4

  1. ncbi Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction
    Anders Malarstig
    Atherosclerosis Research Unit, Karolinska Institute, Stockholm, Sweden
    Arterioscler Thromb Vasc Biol 28:975-82. 2008
    ..INF regulatory factor 5 (IRF5) is one of the mediators of downstream effects of TLRs. Several single nucleotide polymorphisms (SNPs) in the IRF5 gene have been found to be associated with systemic lupus erythematosus...
  2. ncbi Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    Blood 114:1417-22. 2009
    ..Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases...
  3. ncbi Genetics of atherothrombosis and thrombophilia
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine, Solna, Sweden
    Curr Atheroscler Rep 12:159-66. 2010
    ....
  4. ncbi Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
    A Malarstig
    Atherosclerosis Research Unit, Karolinska University Hospital, Stockholm, Sweden
    J Intern Med 270:229-36. 2011
    ..In addition, SNPs in the CD93 gene were studied in relation to plasma CD93 concentration and CD93 mRNA expression...